Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 7/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | CASP7 | P55210 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2426249 | 0.94 | CFTR (0.52) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL21028092 | 0.89 | CFTR (0.63) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL23754117 | 0.84 | GAA (0.46) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL22453008 | 0.83 | CFTR (0.67) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL23930403 | 0.83 | NOTUM (0.48) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL2428349 | 0.80 | CFTR (0.56) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL15797323 | 0.79 | CFTR (0.61) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL5499599 | 0.79 | GAA (0.50) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL2427460 | 0.78 | KDM4E (0.44) | CFTRGAAMAPTKDM4EHPGD | |
| SCHEMBL21032173 | 0.78 | CFTR (0.60) | CFTRGAAMAPTKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254086-A1 | (HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2024-08-01 | — | — | US | disclosed |
| EP-4339187-A1 | (HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2024-03-20 | — | — | EP | disclosed |
| CN-117279895-A | (hetero) arylamide compound and pest control agent | 日本曹达株式会社 | 2023-12-22 | — | — | CN | disclosed |
| WO-2022239798-A1 | (HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT | 日本曹達株式会社 | 2022-11-17 | — | — | WO | disclosed |
| WO-2022239798-A1 | (HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT | 日本曹達株式会社 | 2022-11-17 | — | — | WO | disclosed |
| WO-2021215393-A1 | BENZAMIDE COMPOUND AND PEST CONTROL AGENT | 日本曹達株式会社 (JP) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021215393-A1 | BENZAMIDE COMPOUND AND PEST CONTROL AGENT | 日本曹達株式会社 (JP) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254086-A1 | (HETERO)ARYLAMIDE COMPOUND AND PEST CONTROL AGENT | H1-2, CTRL, BOLA2; BOLA2B | CFTR 2540/4885GAA 3136/4885MAPT 4572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.